- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
22 Depression Trials near Las Vegas, NV
Power is an online platform that helps thousands of Depression patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerPsilocybin Analog for Depression
Trial Details
Key Eligibility Criteria
220 Participants Needed
SP-624 for Depression
Trial Details
Key Eligibility Criteria
456 Participants Needed
SEP-363856 for Major Depressive Disorder
Trial Details
Key Eligibility Criteria
900 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
450 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
460 Participants Needed
Milsaperidone for Depression
Trial Details
Key Eligibility Criteria
500 Participants Needed
Solriamfetol for Depression
Trial Details
Key Eligibility Criteria
300 Participants Needed
NMRA-335140 for Depression
Trial Details
Key Eligibility Criteria
650 Participants Needed
AXS-05 for Depression
Trial Details
Key Eligibility Criteria
350 Participants Needed
Ropanicant for Depression
Trial Details
Key Eligibility Criteria
195 Participants Needed
Zelquistinel for Depression
Trial Details
Key Eligibility Criteria
164 Participants Needed
BHV-7000 for Depression
Trial Details
Key Eligibility Criteria
480 Participants Needed
ALTO-203 for Depression
Trial Details
Key Eligibility Criteria
60 Participants Needed
ABX-002 for Depression
Trial Details
Key Eligibility Criteria
230 Participants Needed
Seltorexant for Depression
Trial Details
Key Eligibility Criteria
752 Participants Needed
NORA520 for Postpartum Depression
Trial Details
Key Eligibility Criteria
90 Participants Needed
LPCN 1154A for Postpartum Depression
Trial Details
Key Eligibility Criteria
80 Participants Needed
ALTO-100 for Bipolar Depression
Trial Details
Key Eligibility Criteria
200 Participants Needed
Fasedienol Nasal Spray for Social Anxiety Disorder
Trial Details
Key Eligibility Criteria
236 Participants Needed
Engage Therapy for Late-Life Depression with Executive Dysfunction
Trial Details
Key Eligibility Criteria
20 Participants Needed
Why Other Patients Applied
"I've experienced drug resistant MDD for 2 decades. I have had no success with CBT and medication, nor either alone. I had success once with TMS, about 5 sessions, in 2014. I have not had TMS since then."
"I have struggled with depression since I was a child. I have experienced about more than 6 major depressive episodes lasting at least 4 months since I was 7 years old. I have tried talk therapy, a plethora of medication, and nothing has worked long term. Medication and talk therapy helps me manage and reduce the length of depressive episodes but I am in search for alternative treatments. My depression has made completing a bachelors degree a major challenge."
"I have tried several different drugs and nothing seems to help really. I'm hoping this trial could give me my life back. I haven't tried anything like psilocybin yet... fingers crossed."
"My long history of depression has been met with a long list of trial and error drugs. My current medication (generic Pristiq) has been prescribed for two decades (though I tried several other medications during my last serious episode several years ago. When the episode passed I returned to generic Pristiq. I am interested in a clinical trial because I wonder if I can do something different to more effectively avoid a serious depressive episode and lift the general malaise I often feel."
"I have dealt with depression my entire adult life. I have been on multiple different meds, went through 10 weeks of TMS treatments (didn't work for me personally), done fairly extensive counseling. I’ve kind of lost hope that anything will ever help me to feel better. But I learned about new meds in clinical trials and I'm ready to try."
BT5528 for Solid Cancers
Trial Details
Key Eligibility Criteria
288 Participants Needed
Dato-DXd + Rilvegostomig for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
675 Participants Needed
Know someone looking for new options?
Spread the word
